Table 1.
Baseline characteristics of CHD women without and with diabetes in the ERA trial.
No Diabetes (N=182) |
Diabetes (N=68) |
P * | |
---|---|---|---|
Age, y | 66 (7) | 64 (7) | 0.01 |
BMI, kg/m2 | 28.22 (7.7) | 33.8 (6.7) | 0.0001 |
Race, % | 0.001 | ||
White | 88 | 69 | |
Black | 8 | 26 | |
Other | 4 | 5 | |
Smoking, % | 24 | 16 | 0.24 |
Lipid lowering medications, % | 33 | 34 | 0.88 |
Plasma glucose, mg/dl | 99 (16) | 170 (51) | 0.0001 |
Systolic blood pressure, mm Hg | 134 (18) | 138 (16) | 0.13 |
Diastolic blood pressure, mm Hg | 74 (8) | 75 (9) | 0.52 |
(N=158) | (N=59) | ||
Min lumen diameter, mm | 1.93 (0.33) | 1.90 (0.40) | 0.49 |
Data are mean (SD);
P value, Mann-Whitney test for continuous variables and Fisher exact test for categorical variables